Search Results 221-230 of 8110 for SC
... SC every 3 weeks in patients with advanced or metastatic sarcoma who are refractory to or intolerant to other available therapies. Also, to evaluate safety ...
The purpose of this study is to evaluate effects on proteinuria and glomerular filtration rate of sibeprenlimab 400 mg subcutaneously (s.c.) Q 4 weeks in ...
These blood clots can travel to the lungs and can become lodged in the blood vessels of the lungs, causing a condition called pulmonary embolism. This medicine ...
... SC, Lindquist NR, Perkins EL, Tan D, Lane JI, Hunter JB, Harvey E, Deep NL, Cerasiello SY, Kircher ML, Espahbodi M, Tooker EL, West NC, Caye-Thomasen P ...
SC-003 is an antibody-drug conjugate (ADC) comprised of a monoclonal antibody linked to a potent chemotherapy. A Study for Women who have Platinum Resistant ...
Lewis completed medical school at the Medical University of South Carolina in Charleston in 1993. She completed residency in internal medicine at the University ...
Howlett LN, Fadadu PP, Grcevich LO, Fought AJ, McGree ME, Giannini A, Butler KA, Tortorella L, Marnholtz AA, Haddock MG, Garda AE, Langstraat CL, Dowdy SC, ...
This neurodegenerative disorder causes nerve cells in the brain and spinal cord to die, blocking signals to the muscles. That results in paralysis that robs a ...
Skip to content. Mayo Clinic Home Page · Request appointment · Log in.
Rezaee-Zavareh MS, Yeo YH, Wang T, Guo Z, Tabrizian P, Ward SC, Barakat F, Hassanein TI, Dave S, Ajmera V, Bhoori S, Mazzaferro V, Chascsa DMH, Liu MC, ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Benefactor support fuels Mayo Clinic’s groundbreaking research. Make a gift today to help us save lives.